Goosehead Insurance (GSHD) will replace NuVasive(NUVA) in the S&P SmallCap 600. S&P MidCap 400 constituent Globus Medical (GMED) is acquiring NuVasive in a deal expected to close soon pending final conditions.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GSHD:
- Goosehead Insurance to replace NuVasive in S&P 600 at open on 9/1
- Goosehead Insurance Introduces an Agency Launch Program to Champion Aspiring Entrepreneurs
- Goosehead Insurance price target raised to $86 from $60.54 at BMO Capital
- Goosehead Insurance price target raised to $80 from $72 at RBC Capital
- Goosehead Insurance price target raised to $76 from $64 at Piper Sandler
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue